Scientists reveal new insights into the human body’s ability to produce broadly neutralizing antibodies to HIV that promise to open new avenues for vaccine development.
Once the HIV enters the body, the immune system starts to produce antibodies to fight the pathogen. Generally, the antibodies produced are specific to the particular strain of HIV.
However, research reveals that around 1 percent of HIV-infected people produce broadly neutralizing antibodies that attack different strains of HIV that circulate worldwide.
